"Potential Link Between RSV Vaccines and Rare Neurological Condition Investigated"

Newly introduced RSV vaccines from GSK and Pfizer have been linked to a slightly increased risk of Guillain-Barré syndrome (GBS), a rare nervous system disorder. More than 20 GBS cases were reported out of 9.5 million vaccine recipients, with the CDC noting that GBS is commonly found in older people in the U.S. and is also associated with other vaccines. While the CDC endorsed the vaccines for certain adults aged 60 and older, officials emphasized the need for ongoing surveillance to determine the magnitude of the risk.